PDC 2019
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
AGENDA – Day 1 • <strong>PDC</strong><br />
Saturday, 30 March <strong>2019</strong><br />
Time Topic Speaker/Chairperson<br />
08:00–08:15 Welcome remarks and meeting objectives Amgad Gamil<br />
Session 1: Pneumococcal Disease in Pediatrics: Global Perspectives<br />
08:15–08:55 PCVs eighteen years after introduction in children: Did we live up to<br />
our expectations?<br />
08:55–09:35 Changes in pneumococcal serotype distribution following the<br />
introduction of pneumococcal vaccination<br />
09:35–10:15 Nasopharyngeal colonization with Streptococcus pneumoniae:<br />
Mechanics of surveillance and lessons learned<br />
Jaime Santos<br />
Ron Dagan<br />
Eun Hwa Choi<br />
Stephen Pelton<br />
10:15–10:40 Coffee Break<br />
10:40–11:10 Pneumococcal nasopharyngeal ecology and herd effect of<br />
pneumococcal conjugate vaccines<br />
11:10–11:40 Why is pneumococcal conjugated vaccine so different from other<br />
vaccines?<br />
Stephen Pelton<br />
Ron Dagan<br />
11:40–12:20 Panel discussion All speakers of Session 1<br />
12:20–13:15 Lunch<br />
Session 2: Pneumococcal Disease in Pediatrics: Regional Perspectives<br />
13:15–13:35 Current epidemiology and serotype distribution of pneumococcal<br />
infections in Taiwan five years after a successful implementation of<br />
PCV13 in the National Immunization Program<br />
13:35–13:55 Epidemiology of pediatric community-acquired pneumonia in<br />
Japan following the introduction of PCV7 and PCV13 in the National<br />
Immunization Program in Japan<br />
13:55–14:15 Improving PCV13 access in the Philippines through the Expanded<br />
Program on Immunization<br />
14:15–14:35 Community-acquired pneumonia in children in India: How PCV13<br />
introduction in the National Immunization Program can benefit Indian<br />
children<br />
Ron Dagan<br />
Chun-Yi Lu<br />
Naruhiko Ishiwada<br />
Anna Ong-Lim<br />
Srinivas G. Kasi<br />
14:35–15:15 Panel discussion All speakers of Session 2<br />
15:15–15:35 Coffee Break<br />
Session 3: Meningococcal Disease Among Risk Groups<br />
Stephen Pelton<br />
15:35–16:05 Epidemiology and risk of meningococcal disease: Global perspective Marco Aurélio Sáfadi<br />
16:05–16:35 Scientific evidence and global recommendation for vaccination of<br />
children against meningococcus<br />
16:35–16:55 Mass gatherings: Expanding vaccination strategies beyond<br />
meningococcal vaccination<br />
Federico Martinón-Torres<br />
Helmy Haja Mydin<br />
16:55–17:25 Panel discussion All speakers of Session 3<br />
17:25–17:30 Closing of Day 1 Amgad Gamil<br />
2
Change language